BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Seminar by Prof. Reinhilde Veugelers\, KU Leuven
DTSTART:20171010T130000
DTEND:20171010T143000
DTSTAMP:20260916T034807Z
UID:b4460bf44b83d7f78e0fdef7ae00c2ba3b60aef51430b69771ffac25
CATEGORIES:Conferences - Seminars
DESCRIPTION:Prof. Reinhilde Veugelers\, KU Leuven\n"The role of small firm
 s\, large firms and universities in the creation\, development and commerc
 ialization of novel inventions in biotech"\nAbstract\nDespite anecdotal ev
 idence\, literature does not provide a clear understanding of how the proc
 ess of novel inventions unfolds. A capabilities-based view leads to a divi
 sion of labour wherein large firms are more efficient at commercializing n
 ovelty\, whereas small firms may either be creators of novelty\, or interm
 ediaries between universities and large firms. Using a new patent-based in
 dicator for technology trajectories and novel data\, we sketch a framework
  to study the role of different actor types in the generation of technolog
 ical novelty\, its follow-on development\, and its commercial application.
  Key preliminary findings indicate an unambiguous relative advantage of sm
 all firms as novelty creators\, and their important role as further develo
 pers\, both internally of own novel inventions and as external reusers of 
 university novelty. Large firms are less active reusers of particularly sm
 all firm novelty.
LOCATION:ODY 4 03 https://plan.epfl.ch/?room==ODY%204%2003
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR